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Abstract The influence of anisoosmolarity on NF-UB binding
activity was studied in H4IIE rat hepatoma cells. Hypoosmo-
larity induced a sustained NF-UB binding activity whereas the
hyperosmotic NF-UB response was only minor. Hypoosmotic
NF-UB activation was accompanied by degradation of the
inhibitory IUB-K. Protein kinase C, PI3-kinase, reactive oxygen
intermediates and the proteasome apparently participate in
mediating the hypoosmotic effect on NF-UB. Hypoosmolarity
plus PMA induced, amplified and prolonged IUB-K degradation
and NF-UB binding activity. Transforming growth factor L-
induced apoptosis was diminished by hypoosmolarity. However,
this anti-apoptotic effect was probably not related to NF-UB
activation.
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1. Introduction
Alterations of hepatic gene expression and metabolic func-
tion occur in response to cell volume alterations under the
in£uence of anisoosmotic environments, hormones, oxidative
stress or cumulative substrate uptake [1]. Osmotic regulation
of metabolism is a result of an activation of osmosensitive
signaling pathways [2].
NF-UB belongs to a family of transcription factors which
are activated by many stimuli including in£ammatory cyto-
kines, phorbol ester, UV irradiation and reactive oxygen in-
termediates [3]. The prototypical NF-UB transcription factor
is a heterodimer consisting of p50 and p65 (RelA) DNA bind-
ing subunits [4]. In unstimulated cells, NF-UB resides in the
cytoplasmatic space as an inactive complex bound to the in-
hibitory subunit IUB. Upon stimulation, speci¢c IUB kinases
are activated and phosphorylated IUB is degraded by the
ubiquitin/proteasome system [5^7]. This releases active NF-
UB which translocates to the nucleus and binds to DNA reg-
ulatory elements of target genes, such as those for cytokines
(IL-1, IL-2, TNF-K), enzymes (e.g. inducible nitric oxide syn-
thase, inducible cyclooxygenase), adhesion molecules (e.g.
ICAM-1, VCAM-1) and receptors (e.g. IL-2 receptor) [8].
The role of NF-UB in regulation of apoptosis is currently
controversially discussed [9^11].
Here, the activation of NF-UB by hypoosmolarity is dem-
onstrated, which is paralleled by proteolytic IUB-K degrada-
tion and which is sensitive to inhibition of protein kinase C
(PKC), PI3-kinase and to antioxidants. NF-UB is not involved
in hypoosmotic protection against transforming growth factor
L (TGF-L)-induced apoptosis.
2. Materials and methods
2.1. Chemicals
Cell culture media were from Gibco BRL (Life Technologies
GmbH, Karlsruhe, Germany) and fetal bovine serum was from
Greiner GmbH (Frickenhausen, Germany). Antibodies against p50,
p65 and IUB-K were obtained from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). MG-132, erbstatin, Go«6850, SB203580, KT5720,
PD098059, LY294002, NF-UB SN50, phorbol 12-myristate 13-acetate
(PMA) were purchased from Calbiochem-Novabiochem GmbH (Bad
Soden, Germany). Sodium orthovanadate, butylated hydroxytoluene
(BHT), butylated hydroxyanisole (BHA), glutathione (reduced form)
(GSH), N-acetyl-L-cysteine (NAC), pyrrolidinedithiocarbamate
(PDTC), TGF-L were from Sigma (Munich, Germany), Poly(dI-dC)
from Pharmacia (Uppsala, Sweden) and [Q-32P]ATP from Amersham
(Braunschweig, Germany). Protease inhibitor cocktail was purchased
from Boehringer (Mannheim, Germany), T4 polynucleotide kinase
and oligonucleotides from Promega (Promega GmbH, Mannheim,
Germany). All other chemicals were from Merck (Darmstadt, Ger-
many).
2.2. Cell culture
H4IIE-C3 rat hepatoma cells were maintained in DMEM/F12 me-
dium supplemented with 10% fetal calf serum (FCS) in a 37‡C, 5%
CO2 atmosphere. When cells reached 90% con£uence, the medium
was changed to DMEM/F12 without FCS for 24 h. Extracellular
osmolarity was adjusted by dilution of the media with the appropiate
volume of the respective NaCl-free medium leading to hypoosmolarity
(205 mosmol/l) or with medium of elevated NaCl content leading to
hyperosmolarity (405 mosmol/l), respectively. Cells were sensitized
with 500 WM sodium vanadate during experimental treatment if not
indicated otherwise.
2.3. Preparation of cytosolic and nuclear extracts
The cells were washed twice with ice cold phosphate-bu¡ered saline
(PBS). After adding bu¡er A (10 mM HEPES pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DTT, 1 mM sodium vanadate, protease
inhibitors), cells were kept on ice for 10 min. Cells were harvested and
nuclei were collected through centrifugation at 10 000Ug. The cyto-
solic supernatant was used for IUB-K Western blot analysis. The nu-
clei were resolved in bu¡er B (20 mM HEPES pH 7.9, 420 mM NaCl,
1.5 mM MgCl2, 0.2 mM EDTA, 25% glycerol, 0.5 mM DTT, 1 mM
sodium vanadate, protease inhibitors). After an incubation period of
20 min on ice, nuclear extract was collected through centrifugation at
3500Ug. The protein concentration of the nuclear supernatant was
measured according to the manufacturer’s instruction (Bio-Rad).
2.4. Electrophoretic mobility shift assay (EMSA)
A double-stranded oligonucleotide containing NF-UB binding site
(5P-AGTTGAGGGGACTTTCCCAGGC-3P) was end-labeled with
[Q-32P]ATP using T4 polynucleotide kinase. The labeled probes were
puri¢ed from free nucleotides using Qiagen Nucleotide Removal kit.
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NF-UB DNA binding reactions were performed in a 30 Wl volume
containing 4^5 Wg of nuclear extract, 6 Wl 5Ubinding bu¡er (20 mM
HEPES pH 7.9, 60 mM KCl, 2 mM MgCl2, 0.1 mM EDTA, 10 mM
DTT, 5% glycerol), 0.3 Wg of poly(dI-dC) and the labeled oligonucleo-
tide. Reactions were incubated at room temperature for 30 min and
analyzed by electrophoresis on a 6% non-denaturating polyacrylamide
gel, 0.5UTBE (50 mM Tris, 50 mM boric acid, 2 mM EDTA) pH 8.2.
Gels were dried and DNA-protein binding complex was localized by
autoradiography for 12 h. For supershift analysis, 0.5 Wg of p50 or
p65 antibody was added.
2.5. IUB-K and poly(ADP-ribose)polymerase (PARP) immunoblot
analysis
For IUB-K immunoblot analysis, 20 Wg of the cytosolic supernatant
was resolved on 10% sodium dodecyl sulfate (SDS)-polyacrylamide
gels and electrotransferred to nitrocellulose ¢lters. Non-speci¢c bind-
ing sites were blocked with Tris-bu¡ered saline (TBS) with 0.1%
Tween 20 (TBST) containing 5% bovine serum albumin (BSA). Mem-
branes were incubated in a 1:1000 dilution of rabbit polyclonal anti-
IUB-K in TBST 2% BSA. After three washes in TBST, membranes
were incubated in a 1:10 000 dilution of horseradish peroxidase-con-
jugated donkey anti-rabbit IgG. Immunoreactive proteins were de-
tected by enhanced chemiluminescence. For PARP immunoblot anal-
ysis, cells were lysed in RIPA (50 mM Tris pH 7.5, 150 mM NaCl, 1%
NP-40, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitors)
and resolved on 8% SDS-polyacrylamide gels. PARP cleavage was
detected by an anti-PARP antibody (Pharmingen).
2.6. Caspase-3 activity
Cells were treated with 5 ng/ml TGF-L for 12 h, washed twice with
PBS, harvested with trypsin and 2 million cells for each reaction were
used. The activity of caspase-3 was determined by using Clontech
colorimetric assay kit according to the manufacturer’s instructions.
3. Results
3.1. Hypoosmotic activation of NF-UB
Activation of NF-UB transcription factor following hypo-
osmotic exposure was shown by EMSA and IUB-K Western
blot analysis. Cells were starved for 12 h prior to exposure to
hypoosmotic (205 mosmol/l), normoosmotic (305 mosmol/l)
and hyperosmotic (405 mosmol/l) medium without (Fig. 1A)
or with sodium orthovanadate at a ¢nal concentration of
500 WM (Fig. 1B). Nuclear and cytosolic extracts were pre-
pared as described and analyzed. Hypoosmotic exposure of
orthovanadate-sensitized cells was followed by a strong and
persistent increase of binding activity. The e¡ect on hyper-
osmolarity was only slight. No NF-UB activation could be
detected under normoosmotic conditions (Fig. 1B), or in ab-
sence of orthovanadate. In agreement with the hypoosmotic-
induced increase of NF-UB binding activity in nucleic extracts,
a reduction of inhibitory subunit IUB-K was observed in the
corresponding cytosolic fractions (Fig. 1B). NF-UB activation
was osmolarity-dependent and already appeared at 245 mos-
mol/l (Fig. 1C). The inducible complex in the gel shift assay
could be identi¢ed as the prototypical p50/p65 heterodimer
using supershift analysis (Fig. 1D).
Fig. 2. E¡ect of antioxidants on NF-UB activation. Cells were
treated with antioxidants at the concentrations indicated for 30 min
prior to hypoosmotic exposure. Cells were harvested and EMSA
was performed as described.
Fig. 1. Induction of NF-UB binding activity and corresponding IUB-
K degradation. (A) Cells were incubated in hypoosmotic (205 mos-
mol/l), normoosmotic (305 mosmol/l) or hyperosmotic (405 mosmol/
l) media without (A) or with (B) orthovanadate for the indicated
time periods. Nucleic extracts were used for gel shift assay. Arrow
shows the inducible complex. Cytosolic supernatants were analyzed
in IUB-K immunoblot assay (B). NF-UB binding activity measured
after 3 h in an anisoosmolar medium ranging from 305 to 205 mos-
mol/l (C). Cells were exposed to 205 mosmol/l for 2.5 h. Inducible
complex was identi¢ed as p50/p65 heterodimer using supershift anal-
ysis with speci¢c p50 and p65 antibodies. Thick arrow indicates the
inducible complex. Thin arrow shows supershift (D).
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3.2. Inhibition of the hypoosmotically induced NF-UB binding
activity by antioxidants
Oxidative stress is a known inducer of NF-UB. Therefore,
the in£uence of antioxidants was examined. As shown in Fig.
2, several antioxidants were able to reduce NF-UB binding
activity after hypoosmotic exposure. These antioxidants in-
cluded chelators (PDTC), synthetic aromatic compounds
(BHT, BHA) and sulfhydryl group donors (NAC and GSH).
3.3. Pharmacological characterization of hypoosmotic-induced
NF-UB binding
As shown in Fig. 3, hypoosmotic NF-UB activation was
sensitive to inhibition of PKC by Go«6850 [12] and inhibition
of PI3-kinase by LY294002 [13]. The reversible proteasome
inhibitor MG-132 [14] decreased transcription factor binding
activity to baseline levels, suggesting an involvement of pro-
teasomes. Protein tyrosine kinases, protein kinase A, MAP
kinase and p38MAPK as kinases with central importance in
signal transduction are apparently not involved in NF-UB
transcription factor regulation as suggested by the lack of
an e¡ect of erbstatin [15], KT5720 [16], PD98059 [17] and
SB203580 [18].
3.4. Modulation of PMA-induced NF-UB activity by
hypoosmolarity
Fig. 4 shows the in£uence of the osmolarity on PMA-in-
duced NF-UB activation. Under normoosmotic conditions,
NF-UB is rapidly activated and translocates to the nucleus
within 1 h of PMA addition. Corresponding to this NF-UB
activation and translocation, a degradation of IUB-K could be
observed. This activation was transient as was the decrease of
IUB-K. The NF-UB binding activity returned to baseline with-
in 6 h.
On the other hand, hypoosmotic-induced NF-UB activation
showed a slower increase of NF-UB binding activity which
was also accompanied by IUB-K degradation. When cells
were treated with hypoosmolarity plus PMA, a long lasting
strong NF-UB binding activity was observed and IUB-K was
downregulated over 6 h.
3.5. E¡ect of hypoosmolarity on TGF-L-induced caspase-3
activity and PARP cleavage
The in£uence of hypoosmotic exposure on cell survival was
measured using the caspase-3 colorimetric assay (Fig. 5).
Whereas caspase-3 activity under normoosmotic and hypoos-
motic conditions showed comparable values, addition of
TGF-L to a ¢nal concentration of 5 ng/ml in normoosmotic
medium caused a signi¢cant increase of caspase-3 activity.
This increase was prevented by decreasing osmolarity to 205
mosmol/l 30 min prior to TGF-L addition. Neither PDTC (1
mM), which inhibits hypoosmotic NF-UB activation (Fig. 5),
nor SN50, a speci¢c NF-UB inhibitor [19], had signi¢cant
e¡ects on the hypoosmotic inhibition of TGF-L-induced acti-
vation of caspase-3 activity. These ¢ndings suggest that NF-
UB is probably not involved in mediating the inhibitory e¡ect
of hypoosmolarity on the TGF-L-induced caspase-3 activa-
tion. In agreement, PARP cleavage appeared only after
TGF-L treatment under normoosmotic conditions (Fig. 5),
but was suppressed by hypoosmolarity regardless of whether
hypoosmotic NF-UB activation was inhibited by PDTC or
not.
Fig. 3. Sensitivity of NF-UB binding activity to proteasome and ki-
nase inhibitors. Cells were treated with inhibitors as indicated 30 min
prior to hypoosmotic exposure. Nucleic extracts were analyzed using
gel shift assay.
Fig. 4. In£uence of osmolarity on NF-UB binding activity and IUB-K degradation following PKC stimulation. Measurement of NF-UB binding
activity after stimulation of H4IIE cells with PMA in normoosmotic medium (305 mosmol/l) or in hypoosmotic medium (205 mosmol/l). Immu-
noblot analysis of IUB-K of corresponding cytosolic supernatant.
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4. Discussion
In the present paper, the hypoosmotic activation of NF-UB
binding towards its speci¢c DNA sequence is reported, which
is accompanied by degradation of IUB-K and which appa-
rently depends on reactive oxygen intermediates (Fig. 2),
PKC and PI3-kinase (Fig. 3). PMA ampli¢es the hypoosmotic
e¡ect on NF-UB activity and IUB-K degradation (Fig. 4). NF-
UB is apparently not involved in mediating the anti-apoptotic
e¡ect of hypoosmolarity on TGF-L-treated H4IIE cells (Fig.
5).
The upstream signalling components mediating hypoos-
motic NF-UB activation di¡er from those leading to hypoos-
motic stimulation of the MAP kinases Erk-1/Erk-2 in H4IIE
cells and hepatocytes, which were sensitive to genistein but
resistant to inhibition of PKC [20,21]. Accordingly, NF-UB
activation remained una¡ected in the presence of PD098059
(Fig. 3), which inhibits the MAP kinase kinase immediately
upstream of Erk-1/Erk-2. Also the hypoosmotic activation of
the p38MAPK observed in H4IIE cells [22] and hepatocytes [23]
is apparently not involved (Fig. 3). A participation of hypo-
osmolarity-induced JNK activation [24] in NF-UB activation
cannot be excluded, although divergent pathways lead to
JNKs and NF-UB in the case of TNF-K-stimulated MCF7
and HeLa cells [25]. Hypoosmolarity activates PI3-kinase
and PKC in hepatocytes [26,27]. In Jurkat cells, PI3-kinase
was recently demonstrated to mediate NF-UB activation up-
stream of IUB-K via activation of the Akt/PKB kinase and the
e¡ect of Akt is most striking if cells are costimulated with
PMA [28]. This would favor the view that PKC and PI3-ki-
nase represent two signalling branches activated by hypo-
osmolarity, which converge upstream of IUB-K degradation
in H4IIE cells. PMA is known to stimulate the generation
of reactive oxygen intermediates in NIH3T3 cells [29], point-
Fig. 5. E¡ect of osmolarity on caspase-3 activity and PARP cleavage of TGF-L-treated cells. Cells were exposed to normoosmotic or hypoos-
motic media as indicated for 30 min. TGF-L was added to a ¢nal concentration of 5 ng/ml and incubation was continued for a period of 12 h
(caspase-3) or 8 h (PARP). Cells were harvested as described. For NF-UB inhibition, PDTC (1 mM) and speci¢c translocation inhibitor NF-UB
SN50 (20 WM) were added 30 min prior to anisoosmolar stimulation. Caspase-3 activity was measured by colorimetric assay. PARP cleavage
was visualized by immunoblot analysis.
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ing to a potential role of PKC in redox signalling towards
NF-UB. PMA induces a transient NF-UB activation in
H4IIE cells, accompanied by IUB-K degradation and followed
by resynthesis of IUB-K (Fig. 4), which probably induces
downregulation of NF-UB binding activity within a feedback
loop. The reason for interruption of feedback inhibition under
hypoosmotic conditions (Fig. 4) is yet unknown, but may
contribute to sustained NF-UB activation observed under cer-
tain conditions [30].
Hypoosmotic cell swelling downregulates autophagic pro-
teolysis in the liver [23]. Contrasting to the e¡ect on overall
hepatic proteolysis, hypoosmolarity stimulates the degrada-
tion of IUB-K (Figs. 1 and 4), which is known to occur via
the ubiquitin/proteasome pathway. Obviously, hypoosmolar-
ity exerts di¡erential e¡ects on the degradation rate of single
proteins. To what extent the proteasome pathway underlies
regulation by cell hydration remains to be determined.
Con£icting data exist with respect to the relation of NF-UB
to the apoptotic process. In HEK 293 cells, activation of NF-
UB was suggested to be involved in mediating apoptosis [31].
In contrast, NF-UB suppressed TNF-K-induced apoptosis in
HEF cells [32]. Insulin, which activates NF-UB and PI3-kinase
via di¡erent signalling branches, exerts its anti-apoptotic func-
tion by both a NF-UB- and a PI3-kinase-dependent pathway
[33]. In line with the protective e¡ect of hypoosmotic swelling
on cells challenged with oxidative stress or heat shock [24,34^
36], hypoosmolarity abolishes TGF-L-induced activation of
caspase-3 and PARP cleavage (Fig. 5). However, blockade
of NF-UB activation by the antioxidant PDTC is without
in£uence on the anti-apoptotic e¡ect exerted by hypoosmotic
swelling (Fig. 5). One can speculate that signalling compo-
nents di¡erent from NF-UB such as PI3-kinase mediate the
anti-apoptotic e¡ect of hypoosmolarity. Alternatively, hypo-
osmotic swelling may interfere with cell shrinkage, which is an
obligatory event during the apoptotic cell death.
Although the functional importance of hypoosmotic NF-UB
activation in liver remains to be established, it likely contrib-
utes to osmotic regulation of hepatic gene expression and
modulation of signalling induced by hormones and stress con-
ditions.
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